113 related articles for article (PubMed ID: 6436021)
1. In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa.
Righter J
Eur J Clin Microbiol; 1984 Aug; 3(4):368-9. PubMed ID: 6436021
[No Abstract] [Full Text] [Related]
2. Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.
Turcotte A; Simard M; Morin NJ; Beauchamp D; Bergeron MG
Antimicrob Agents Chemother; 1997 Feb; 41(2):401-9. PubMed ID: 9021198
[TBL] [Abstract][Full Text] [Related]
3. Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Pohlman JK; Knapp CC; Ludwig MD; Washington JA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):29-33. PubMed ID: 8950526
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
[TBL] [Abstract][Full Text] [Related]
5. In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
Davies GS; Cohen J
J Antimicrob Chemother; 1985 Dec; 16(6):713-7. PubMed ID: 2936706
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Meyer RD; Pasiecznik K
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.
Bustamante CI; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1814-5. PubMed ID: 2126693
[TBL] [Abstract][Full Text] [Related]
8. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
Ullmann U; Lindemann B
Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
Gerçeker AA; Gürler B
J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
[TBL] [Abstract][Full Text] [Related]
10. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Pendland SL; Messick CR; Jung R
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
Ramadan MA; Tawfik AF; Shibl AM
Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
[TBL] [Abstract][Full Text] [Related]
12. Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.
Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
Infection; 1983; 11(6):326-8. PubMed ID: 6421743
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
15. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
Elliott TS; Greenwood D
J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
17. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.
Díez Enciso M
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):90-2. PubMed ID: 1907544
[No Abstract] [Full Text] [Related]
19. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
Van Laethem Y; Husson M; Klastersky J
Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).
Sader HS; Castanheira M; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2015 Dec; 83(4):389-94. PubMed ID: 26162518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
